A citation-based method for searching scientific literature

Craig L Leonardi, Kyoungah See, Russel Burge, Zhuoer Sun, Ying Zhang, Lotus Mallbris, Alyssa Garrelts, Richard B Warren. Adv Ther 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses.
April W Armstrong, Emily Edson-Heredia, April N Naegeli, Russel Burge, Jiat-Ling Poon, Milena Anatchkova, Luna Sun, Baojin Zhu, Kathleen W Wyrwich. J Dermatolog Treat 2020
3
50

Psoriasis treatment patterns: a retrospective claims study.
Sara Higa, Beth Devine, Vaishali Patel, Sarah Baradaran, Degang Wang, Aasthaa Bansal. Curr Med Res Opin 2019
9
50

Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis.
April W Armstrong, Luis Puig, Avani Joshi, Martha Skup, David Williams, Junlong Li, Keith A Betts, Matthias Augustin. JAMA Dermatol 2020
83
50

Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data.
April W Armstrong, J Will Koning, Simon Rowse, Huaming Tan, Carla Mamolo, Mandeep Kaur. Dermatol Ther (Heidelb) 2017
34
50

Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.
Howa Yeung, Joy Wan, Abby S Van Voorhees, Kristina Callis Duffin, Gerald G Krueger, Robert E Kalb, Jamie D Weisman, Brian R Sperber, Bruce A Brod, Stephen M Schleicher,[...]. J Am Acad Dermatol 2013
84
50

Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort study.
Erica D Dommasch, Moa P Lee, Cara J Joyce, Elizabeth M Garry, Joshua J Gagne. J Am Acad Dermatol 2018
16
50

Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption.
K B Gordon, A B Gottlieb, R G Langely, P van de Kerkhof, K T Belasco, M Sundaram, M Okun, L Serra. J Eur Acad Dermatol Venereol 2015
16
50

Psoriasis Prevalence in Adults in the United States.
April W Armstrong, Manan D Mehta, Clayton W Schupp, George C Gondo, Stacie J Bell, Christopher E M Griffiths. JAMA Dermatol 2021
32
50

Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.
Marie Masson Regnault, Jason Shourick, Fatma Jendoubi, Marie Tauber, Carle Paul. Am J Clin Dermatol 2022
5
50



Restarting Biologic Agents After a Drug Holiday.
David T Rubin. Gastroenterol Hepatol (N Y) 2019
6
50

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
Alan Menter, Steven R Feldman, Gerald D Weinstein, Kim Papp, Robert Evans, Cynthia Guzzo, Shu Li, Lisa T Dooley, Cynthia Arnold, Alice B Gottlieb. J Am Acad Dermatol 2007
354
50

Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population.
Jalpa A Doshi, Junko Takeshita, Lionel Pinto, Penxiang Li, Xinyan Yu, Preethi Rao, Hema N Viswanathan, Joel M Gelfand. J Am Acad Dermatol 2016
70
50

Shared Decision Making in Psoriasis: A Systematic Review of Quantitative and Qualitative Studies.
Marie Hamilton Larsen, Kåre Birger Hagen, Anne Lene Krogstad, Astrid Klopstad Wahl. Am J Clin Dermatol 2019
12
50

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Alan Menter, Bruce E Strober, Daniel H Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W Armstrong, Cody Connor, Kelly M Cordoro, Dawn M R Davis,[...]. J Am Acad Dermatol 2019
303
50

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
Craig A Elmets, Craig L Leonardi, Dawn M R Davis, Joel M Gelfand, Jason Lichten, Nehal N Mehta, April W Armstrong, Cody Connor, Kelly M Cordoro, Boni E Elewski,[...]. J Am Acad Dermatol 2019
157
50

Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review.
Aleksandra G Florek, Catherine J Wang, April W Armstrong. Arch Dermatol Res 2018
50
50



Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease.
Irina Deeva, Serena Mariani, Chiara De Luca, Valeria Pacifico, Luca Leoni, Desanka Raskovic, Zaira Kharaeva, Liudmila Korkina, Saveria Pastore. Cytokine 2010
39
50

Psoriatic erythroderma: a histopathologic study of forty-five patients.
C Tomasini, F Aloi, C Solaroli, M Pippione. Dermatology 1997
14
50

Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis.
G Avallone, C Cariti, P Dapavo, M Ortoncelli, L Conforto, L Mastorino, G Roccuzzo, F Cavallo, M Rubatto, P Quaglino,[...]. J Eur Acad Dermatol Venereol 2022
5
50

Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
Leonardo Pescitelli, Valentina Dini, Paolo Gisondi, Francesco Loconsole, Stefano Piaserico, Angelo Piccirillo, Giuseppe Stinco, Enzo Errichetti, Marina Talamonti, Lara Tripo,[...]. J Dermatol Sci 2015
11
50


Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Philip Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel Kremer, Jeffrey Greenberg, Wendi Malley, Alina Onofrei,[...]. Ann Rheum Dis 2020
78
50

Treatment of erythrodermic psoriasis with etanercept.
M Esposito, A Mazzotta, C de Felice, M Papoutsaki, S Chimenti. Br J Dermatol 2006
36
50


Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study.
Giovanni Damiani, Alessia Pacifico, Filomena Russo, Paolo Daniele Maria Pigatto, Nicola Luigi Bragazzi, Claudio Bonifati, Aldo Morrone, Abdulla Watad, Mohammad Adawi. J Clin Med 2019
14
50

Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.
Laura M Sawyer, Kinga Malottki, Celia Sabry-Grant, Najeeda Yasmeen, Emily Wright, Anne Sohrt, Emma Borg, Richard B Warren. PLoS One 2019
81
50




Serum immunoglobulins in psoriatic erythroderma.
L-F Li, S A Sujan, H Yang, W-H Wang. Clin Exp Dermatol 2005
23
50

Long-term remission induced by secukinumab in a 13-year-old boy having recalcitrant chronic erythrodermic psoriasis.
Sunil Dogra, Anuradha Bishnoi, Tarun Narang, Sanjeev Handa. Dermatol Ther 2018
9
50


Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
Xanthippe-Argyro Koutsoukou, Evangelia Papadavid, Konstantinos Theodoropoulos, Dimitris Rigopoulos. Dermatol Ther 2014
8
50

Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies.
J Santos-Juanes, P Coto-Segura, A Mas-Vidal, C Galache Osuna. Br J Dermatol 2010
29
50

Exposure-Response Relationships for the Efficacy and Safety of Risankizumab in Japanese Subjects with Psoriasis.
Ahmed A Suleiman, Amit Khatri, Rajneet K Oberoi, Ahmed A Othman. Clin Pharmacokinet 2020
10
50

Total Serum Immunoglobulin E Levels in Patients with Psoriasis.
Emina Kasumagic-Halilovic. Mater Sociomed 2020
8
50

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis.
April Armstrong, Kyle Fahrbach, Craig Leonardi, Matthias Augustin, Binod Neupane, Paulina Kazmierska, Marissa Betts, Andreas Freitag, Sandeep Kiri, Vanessa Taieb,[...]. Dermatol Ther (Heidelb) 2022
2
50

Erythrodermic psoriasis improved by panitumumab, but not bevacizumab.
Aya Nishizawa, Takahiro Satoh, Hiroo Yokozeki. Acta Derm Venereol 2012
7
50

Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial.
Kristian Reich, Kim A Papp, Andrew Blauvelt, Richard G Langley, April Armstrong, Richard B Warren, Kenneth B Gordon, Joseph F Merola, Yukari Okubo, Cynthia Madden,[...]. Lancet 2021
55
50

Analysis of Th1/Th2 response pattern for erythrodermic psoriasis.
Ping Zhang, Hong-Xiang Chen, Yi-Qun Duan, Wei-Zhen Wang, Tian-Zhu Zhang, Jia-Wen Li, Ya-Ting Tu. J Huazhong Univ Sci Technolog Med Sci 2014
20
50

Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
Misha Rosenbach, Sylvia Hsu, Neil J Korman, Mark G Lebwohl, Melodie Young, Bruce F Bebo, Abby S Van Voorhees. J Am Acad Dermatol 2010
87
50

Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
Hannele Heikkilä, Annamari Ranki, Suvi Cajanus, Seija-Liisa Karvonen. Arch Dermatol 2005
25
50

Erythrodermic psoriasis in a dialyzed patient successfully treated with Secukinumab.
Laura Pizzatti, Cristina Mugheddu, Silvia Sanna, Laura Atzori, Franco Rongioletti. Dermatol Ther 2020
3
50

Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.
U F Haustein, M Rytter. J Eur Acad Dermatol Venereol 2000
92
50

Treating psoriasis in the elderly: biologics and small molecules.
Matteo Megna, Luca Potestio, Gabriella Fabbrocini, Elisa Camela. Expert Opin Biol Ther 2022
6
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.